Supernus Pharmaceuticals | Betriebsaufwand



Operating Expenses Veränderung Datum
Abbott USD 9.07B 369M 2025-06
ANI Pharmaceuticals USD 196.2M 25.27M 2025-06
Aurora Cannabis CAD 118.24M 66.26M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Canopy Growth CAD 94.22M 4.36M 2025-06
Corcept Therapeutics USD 167.76M 13.96M 2025-06
Eisai JPY 181.91B 7.35B 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Novo Nordisk 42.77B 3.48B 2025-06
Pacira USD 170.87M 3.93M 2025-06
Perrigo USD 1B 36.2M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Supernus Pharmaceuticals USD 153.31M 892K 2025-06
United Therapeutics USD 521.7M 110.1M 2025-06
Xeris Pharmaceuticals USD 67.06M 8.64M 2025-06


Supernus Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.